What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. Diagnostics 2023, 13, 2299

Abstract

I read with great interest the article by Akitaka Yamamoto et al. that was recently published in Diagnostics [...]

Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. Diagnostics 2023, 13, 2299”

“…Dr. Ishikura also focused on the importance of the underlying diseases of DIC. The underlying diseases of DIC differed between Ishikura et al [ 1 , 3 ] and our studies [ 2 , 13 ]. In Dr. Ishikura’s studies, the underlying disease was sepsis in most cases, while the underlying diseases in our study were heterogeneous [ 2 , 13 ].…”

“…We would like to thank Dr. Ishikura for his kind comment [ 1 ] on our recent article describing the early diagnosis of disseminated intravascular coagulation (DIC) or pre-DIC using a super formula that includes soluble C-type lectin-like receptor 2 (sCLEC-2), a novel platelet activation biomarker, platelet count (PLT), and D-dimer [ 2 ].…”